$DBD
DIEBOLD NIXDORF, Inc Stock $dbd

$dbd Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000002882323000117 Filed on May 30, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$922.2M	$858.1M	$829.8M
YoY Change	8.28%	3.41%	-12.09%
Cost Of Revenue	$697.0M	$648.8M	$644.5M
YoY Change	2.83%	0.67%	-3.91%
Gross Profit	$225.2M	$209.3M	$185.3M
YoY Change	29.5%	12.95%	-32.17%
Gross Profit Margin	24.42%	24.39%	22.33%
Selling, General & Admin	$201.0M	$183.8M	$181.0M
YoY Change	28.93%	1.55%	-11.01%
% of Gross Profit	89.25%	87.82%	97.68%
Research & Development	$25.40M	$26.40M	$32.30M
YoY Change	-1.55%	-18.27%	-5.28%
% of Gross Profit	11.28%	12.61%	17.43%
Depreciation & Amortization	$31.10M	$11.70M	$14.50M
YoY Change	-3.42%	-19.31%	-26.77%
% of Gross Profit	13.81%	5.59%	7.83%
Operating Expenses	$229.1M	$211.4M	$268.7M
YoY Change	26.09%	-21.32%	13.38%
Operating Profit	-$3.900M	-$2.100M	-$83.40M
YoY Change	-50.0%	-97.48%	-330.39%
Interest Expense	$69.70M	$81.90M	$48.10M
YoY Change	-250.54%	70.27%	-1.23%
% of Operating Profit
Other Income/Expense, Net	-$697.6M	-$88.20M	-$48.90M
YoY Change	-15265.22%	80.37%	16.43%
Pretax Income	-$701.5M	-$90.30M	-$132.3M
YoY Change	426.65%	-31.75%	2181.03%
Income Tax	-$24.80M	$21.10M	$50.90M
% Of Pretax Income
Net Earnings	-$677.1M	-$111.1M	-$183.1M
YoY Change	239.91%	-39.32%	2160.49%
Net Earnings / Revenue	-73.42%	-12.95%	-22.07%
Basic Earnings Per Share	-$8.46	-$1.40	-$2.33
Diluted Earnings Per Share	-$8.46	-$1.40	-$2.327M
COMMON SHARES
Basic Shares Outstanding	80.04M shares	79.61M shares	78.70M shares
Diluted Shares Outstanding	80.00M shares	79.30M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$552.8M	$263.0M	$266.8M
YoY Change	96.52%	-1.42%	4.18%
Cash & Equivalents	$541.8M	$246.4M	$224.7M
Short-Term Investments	$11.00M	$16.60M	$42.10M
Other Short-Term Assets	$224.5M	$219.5M	$233.7M
YoY Change	-37.98%	-6.08%	-5.23%
Inventory	$648.3M	$639.5M	$620.8M
Prepaid Expenses	$46.70M	$53.20M	$49.50M
Receivables	$655.9M	$627.1M	$549.8M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.136B	$1.809B	$1.782B
YoY Change	15.56%	1.55%	-0.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$119.1M	$120.1M	$131.5M
YoY Change	1.62%	-8.67%	-16.08%
Goodwill	$713.4M	$702.2M	$731.9M
YoY Change		-4.06%	-5.12%
Intangibles	$226.8M	$245.1M	$324.2M
YoY Change		-24.4%	-21.06%
Long-Term Investments	$7.000M	$7.400M	$9.700M
YoY Change	-14.63%	-23.71%	-6.73%
Other Assets	$248.0M	$251.9M	$287.8M
YoY Change	8.3%	-12.47%	-8.58%
Total Long-Term Assets	$1.269B	$1.282B	$1.535B
YoY Change	-4.82%	-16.51%	-10.9%
TOTAL ASSETS
Total Short-Term Assets	$2.136B	$1.809B	$1.782B
Total Long-Term Assets	$1.269B	$1.282B	$1.535B
Total Assets	$3.406B	$3.091B	$3.317B
YoY Change	7.02%	-6.81%	-5.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$504.1M	$636.4M	$623.9M
YoY Change	-29.8%	2.0%	14.08%
Accrued Expenses	$142.3M	$121.9M	$165.2M
YoY Change	5.25%	-26.21%	-17.97%
Deferred Revenue
YoY Change
Short-Term Debt	$417.0M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.252B	$83.70M	$10.40M
YoY Change	11491.67%	704.81%	-5.45%
Total Short-Term Liabilities	$3.090B	$1.743B	$1.663B
YoY Change	86.54%	4.84%	2.06%
LONG-TERM LIABILITIES
Long-Term Debt	$4.400M	$2.572B	$2.341B
YoY Change	-99.82%	9.88%	3.07%
Other Long-Term Liabilities	$95.60M	$107.1M	$136.0M
YoY Change	-57.57%	-21.25%	-7.29%
Total Long-Term Liabilities	$95.60M	$107.1M	$136.0M
YoY Change	-96.37%	-21.25%	-7.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.090B	$1.743B	$1.663B
Total Long-Term Liabilities	$95.60M	$107.1M	$136.0M
Total Liabilities	$3.296B	$1.850B	$1.799B
YoY Change	-25.76%	2.86%	1.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.195B	-$1.518B	-$1.006B
YoY Change		50.95%	34.0%
Common Stock	$953.3M	$952.6M	$939.6M
YoY Change		1.38%	1.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$586.4M	$586.4M	$585.4M
YoY Change		0.17%	0.6%
Treasury Stock Shares			16.64M shares
Shareholders Equity	-$2.135B	-$1.485B	-$1.017B
YoY Change
Total Liabilities & Shareholders Equity	$3.406B	$3.091B	$3.317B
YoY Change	7.02%	-6.81%	-5.66%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$677.1M	-$111.1M	-$183.1M
YoY Change	239.91%	-39.32%	2160.49%
Depreciation, Depletion And Amortization	$31.10M	$11.70M	$14.50M
YoY Change	-3.42%	-19.31%	-26.77%
Cash From Operating Activities	-$241.0M	-$95.90M	-$226.2M
YoY Change	196.07%	-57.6%	246.93%
INVESTING ACTIVITIES
Capital Expenditures	$5.500M	$5.700M	-$4.000M
YoY Change	-234.15%	-242.5%	60.0%
Acquisitions
YoY Change
Other Investing Activities	$600.0K	$4.000M	-$1.800M
YoY Change	-80.0%	-322.22%	-131.58%
Cash From Investing Activities	-$4.900M	-$1.700M	-$5.800M
YoY Change	345.45%	-70.69%	-281.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$5.000M
YoY Change			-13.79%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	542.3M	$21.10M	$65.60M
YoY Change	372.8%	-67.84%	-363.45%
NET CHANGE
Cash From Operating Activities	-241.0M	-$95.90M	-$226.2M
Cash From Investing Activities	-4.900M	-$1.700M	-$5.800M
Cash From Financing Activities	542.3M	$21.10M	$65.60M
Net Change In Cash	296.4M	-$74.60M	-$164.9M
YoY Change	820.5%	-54.76%	85.91%
FREE CASH FLOW
Cash From Operating Activities	-$241.0M	-$95.90M	-$226.2M
Capital Expenditures	$5.500M	$5.700M	-$4.000M
Free Cash Flow	-$246.5M	-$101.6M	-$222.2M
YoY Change	218.89%	-54.28%	254.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000028823
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-4879
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Diebold Nixdorf, Incorporated
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OH
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	34-0183970
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	50 Executive Parkway, P.O. Box 2520
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Hudson
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	44236
CY2023Q1	dei	City Area Code CityAreaCode	330
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	490-4000
CY2023Q1	dei	Security12b Title Security12bTitle	Common shares, $1.25 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	DBD
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	80037406	shares
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246400000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	319100000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	16600000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	24600000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	32400000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	34500000	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	627100000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	612200000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	639500000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	588100000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	53200000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	50500000	usd
CY2023Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	6900000	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	7900000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	219500000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	168500000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1809200000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1770900000	usd
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	7400000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	7600000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	490100000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	479400000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	120100000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	120700000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	702200000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	702300000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	251900000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	249900000	usd
CY2023Q1	us-gaap	Assets Assets	3090700000	usd
CY2022Q4	us-gaap	Assets Assets	3065000000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	83700000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	24000000.0	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	636400000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	611600000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	486700000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	453200000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	121900000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	107900000	usd
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	8500000	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	6800000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	405700000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	401400000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1742900000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1604900000	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2571700000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2585800000	usd
CY2023Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	41900000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	40600000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	100700000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	96600000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	107100000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	108200000	usd
CY2022Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.25
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.25
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	96563247	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	95779719	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79609121	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79103450	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	120800000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	119800000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	831800000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	831500000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1517800000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1406700000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	16954126	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	16676269	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	586400000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	585600000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-353700000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-360000000.0	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	20100000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	20100000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1485200000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1380900000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	11600000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	9800000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1473600000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1371100000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3090700000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3065000000	usd
CY2023Q1	us-gaap	Revenues Revenues	858100000	usd
CY2022Q1	us-gaap	Revenues Revenues	829800000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	648800000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	644500000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	209300000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	185300000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	183800000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	181000000.0	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26400000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32300000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-300000	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-200000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	900000	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	55200000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	211400000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	268700000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2100000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-83400000	usd
CY2023Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1700000	usd
CY2022Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1300000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	81900000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	48100000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10600000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4700000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2600000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2600000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-90300000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-132300000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21100000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	50900000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-100000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-700000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-111500000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-183900000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-400000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-800000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79300000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78700000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.40
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.33
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-111500000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-183900000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	300000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	2900000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-600000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	300000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	2300000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	1300000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	700000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	700000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8500000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	13900000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-103000000.0	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-170000000.0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1800000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-104800000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-170000000.0	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-111500000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-183900000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11700000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14500000	usd
CY2023Q1	dbd	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	17700000	usd
CY2022Q1	dbd	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	18500000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	13600000	usd
CY2022Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	4300000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1300000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1700000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-300000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-200000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	900000	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	55200000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-2900000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	0	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-800000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4400000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-35200000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	39600000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	83000000.0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	15400000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-77700000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	25500000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	54200000	usd
CY2023Q1	dbd	Increase Decrease In Sales Tax And Net Value Added Tax IncreaseDecreaseInSalesTaxAndNetValueAddedTax	-24300000	usd
CY2022Q1	dbd	Increase Decrease In Sales Tax And Net Value Added Tax IncreaseDecreaseInSalesTaxAndNetValueAddedTax	-24800000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	2800000	usd
CY2022Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-38100000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	11300000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-21300000	usd
CY2023Q1	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-23400000	usd
CY2022Q1	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-11500000	usd
CY2023Q1	dbd	Increase Decrease In Warranty Reserve IncreaseDecreaseInWarrantyReserve	-1100000	usd
CY2022Q1	dbd	Increase Decrease In Warranty Reserve IncreaseDecreaseInWarrantyReserve	-400000	usd
CY2023Q1	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	3000000.0	usd
CY2022Q1	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-22500000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-6800000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	23000000.0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-95900000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-226200000	usd
CY2023Q1	dbd	Payments To Acquire Property Plant And Equipment Including Software PaymentsToAcquirePropertyPlantAndEquipmentIncludingSoftware	5700000	usd
CY2022Q1	dbd	Payments To Acquire Property Plant And Equipment Including Software PaymentsToAcquirePropertyPlantAndEquipmentIncludingSoftware	4000000.0	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	5400000	usd
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	7600000	usd
CY2023Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	usd
CY2022Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	-5800000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	71900000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	126800000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	62500000	usd
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	126800000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1700000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5800000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	22700000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	75000000.0	usd
CY2023Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	2300000	usd
CY2022Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	300000	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	2100000	usd
CY2022Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	4700000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1800000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5000000.0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21100000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	65600000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1900000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1500000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-74600000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-164900000	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	2800000	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	3100000	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	900000	usd
CY2022Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	2400000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	319100000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	388900000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246400000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	224700000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dbd	Incremental Shares Excluded From Dilutive Calculation Due To Resultingin Operating Loss IncrementalSharesExcludedFromDilutiveCalculationDueToResultinginOperatingLoss	2100000	shares
CY2022Q1	dbd	Incremental Shares Excluded From Dilutive Calculation Due To Resultingin Operating Loss IncrementalSharesExcludedFromDilutiveCalculationDueToResultinginOperatingLoss	1400000	shares
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-111500000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-183900000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-400000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-800000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-111100000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-183100000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79300000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78700000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.40
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.33
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2200000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4000000.0	shares
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.234
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.383
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	220000000.0	usd
CY2022Q4	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	200600000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	247900000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	229400000	usd
CY2023Q1	dbd	Other Inventories Spare Parts Net Of Reserves OtherInventoriesSparePartsNetOfReserves	171600000	usd
CY2022Q4	dbd	Other Inventories Spare Parts Net Of Reserves OtherInventoriesSparePartsNetOfReserves	158100000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	639500000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	588100000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Life Insurance Corporate Or Bank Owned Amount LifeInsuranceCorporateOrBankOwnedAmount	3200000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	1173200000	usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	470900000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	702300000	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-100000	usd
CY2023Q1	us-gaap	Goodwill Gross GoodwillGross	1173100000	usd
CY2023Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	470900000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	702200000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1027600000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	782500000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	245100000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1004900000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	747300000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	257600000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	5400000	usd
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	7600000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	4700000	usd
CY2022Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	5300000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	23300000	usd
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	24300000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	28300000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	37200000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	9100000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	4900000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	10200000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5300000	usd
CY2023Q1	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	700000	usd
CY2022Q1	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	500000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	27900000	usd
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	37300000	usd
CY2023Q1	us-gaap	Other Restructuring Costs OtherRestructuringCosts	150000000.0	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	1819.7	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	15000000.0	usd
CY2022Q1	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	44200000	usd
CY2021Q4	us-gaap	Restructuring Reserve RestructuringReserve	35300000	usd
CY2023Q1	us-gaap	Severance Costs1 SeveranceCosts1	4800000	usd
CY2022Q1	us-gaap	Severance Costs1 SeveranceCosts1	0	usd
CY2023Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	28200000	usd
CY2022Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	11600000	usd
CY2023Q1	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	300000	usd
CY2022Q1	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	-300000	usd
CY2023Q1	us-gaap	Restructuring Reserve RestructuringReserve	21100000	usd
CY2022Q1	us-gaap	Restructuring Reserve RestructuringReserve	23400000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dbd	Uncommitted Lines Of Credit UncommittedLinesOfCredit	3900000	usd
CY2022Q4	dbd	Uncommitted Lines Of Credit UncommittedLinesOfCredit	900000	usd
CY2023Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	300000	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1700000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	3800000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	3000000.0	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	83700000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	24000000.0	usd
CY2023Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	5300000	usd
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	6300000	usd
CY2023Q1	dbd	Long Term Debt Excluding Debt Issuance Costs LongTermDebtExcludingDebtIssuanceCosts	2700800000	usd
CY2022Q4	dbd	Long Term Debt Excluding Debt Issuance Costs LongTermDebtExcludingDebtIssuanceCosts	2724800000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	129100000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	139000000.0	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2571700000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2585800000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	102700000	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	188000000.0	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	80000000.0	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	113000000.0	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	2100000	usd
CY2022Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	4700000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	20100000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1371100000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-111500000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8500000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1300000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	800000	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	20100000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1473600000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-837000000.0	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-183900000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	13900000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1700000	usd
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3300000	usd
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1008600000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-360000000.0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	5000000.0	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-1300000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	6300000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-353700000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-2200000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-378500000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	13000000.0	usd
CY2022Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-100000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	13100000	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-365400000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-800000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-800000	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-1300000	usd
CY2022Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-100000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	17500000	usd
CY2022Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	21800000	usd
CY2023Q1	dbd	Benefit Plan Plan Assets Reimbursementfrom Cta BenefitPlanPlanAssetsReimbursementfromCTA	17000000.0	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dbd	Fair Value Transfers Between Levels Amount FairValueTransfersBetweenLevelsAmount	0	usd
CY2022Q1	dbd	Fair Value Transfers Between Levels Amount FairValueTransfersBetweenLevelsAmount	0	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	2573.8	usd
CY2023Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	1441	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2557.6	usd
CY2017Q1	dbd	Shares Repurchased Of Redeemable Noncontrolling Interest SharesRepurchasedOfRedeemableNoncontrollingInterest	6900000	shares
CY2019Q2	dbd	Shares Repurchased Of Redeemable Noncontrolling Interest SharesRepurchasedOfRedeemableNoncontrollingInterest	1400000	shares
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	140600000	usd
CY2022Q4	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	173200000	usd
CY2023Q1	dbd	Revenue From Contract With Customer Percentage RevenueFromContractWithCustomerPercentage	1
CY2022Q1	dbd	Revenue From Contract With Customer Percentage RevenueFromContractWithCustomerPercentage	1
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	612200000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	453200000	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	627100000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	486700000	usd
CY2023Q1	dbd	Impairment Losses Recognized As Bad Debt Expense ImpairmentLossesRecognizedAsBadDebtExpense	7200000	usd
CY2022Q1	dbd	Impairment Losses Recognized As Bad Debt Expense ImpairmentLossesRecognizedAsBadDebtExpense	4600000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	453200000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	122100000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1400000000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	200000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	200000	usd
CY2023Q1	us-gaap	Sales Type Lease Unguaranteed Residual Asset SalesTypeLeaseUnguaranteedResidualAsset	100000	usd
CY2022Q4	us-gaap	Sales Type Lease Unguaranteed Residual Asset SalesTypeLeaseUnguaranteedResidualAsset	100000	usd
CY2023Q1	dbd	Capital Leases Net Investment In Sales Type Leases Minimum Payments To Be Received And Unguaranteed Residual Values CapitalLeasesNetInvestmentInSalesTypeLeasesMinimumPaymentsToBeReceivedAndUnguaranteedResidualValues	29300000	usd
CY2022Q4	dbd	Capital Leases Net Investment In Sales Type Leases Minimum Payments To Be Received And Unguaranteed Residual Values CapitalLeasesNetInvestmentInSalesTypeLeasesMinimumPaymentsToBeReceivedAndUnguaranteedResidualValues	28000000.0	usd
CY2023Q1	dbd	Capital Leases Net Investment In Sales Type Leases Unearned Interest Income CapitalLeasesNetInvestmentInSalesTypeLeasesUnearnedInterestIncome	1500000	usd
CY2022Q4	dbd	Capital Leases Net Investment In Sales Type Leases Unearned Interest Income CapitalLeasesNetInvestmentInSalesTypeLeasesUnearnedInterestIncome	1500000	usd
CY2023Q1	dbd	Capital Leases Net Investment In Sales Type Leases Receivable Net CapitalLeasesNetInvestmentInSalesTypeLeasesReceivableNet	27800000	usd
CY2022Q4	dbd	Capital Leases Net Investment In Sales Type Leases Receivable Net CapitalLeasesNetInvestmentInSalesTypeLeasesReceivableNet	26500000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths	7300000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears	5900000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears	5200000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears	5000000.0	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Five Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears	3700000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Thereafter SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter	2300000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	29400000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Revenues Revenues	858100000	usd
CY2022Q1	us-gaap	Revenues Revenues	829800000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2100000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-83400000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-88200000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-48900000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-90300000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-132300000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Revenues Revenues	858100000	usd
CY2022Q1	us-gaap	Revenues Revenues	829800000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	50700000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	38400000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	19.6	usd
CY2023Q1	us-gaap	Capitalized Computer Software Period Increase Decrease CapitalizedComputerSoftwarePeriodIncreaseDecrease	0.8	usd
CY2022Q1	us-gaap	Capitalized Computer Software Period Increase Decrease CapitalizedComputerSoftwarePeriodIncreaseDecrease	0.5	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31

Files In Submission

Name	View Source	Status
0000028823-23-000117-index-headers.html	Edgar Link	pending
0000028823-23-000117-index.html	Edgar Link	pending
0000028823-23-000117.txt	Edgar Link	pending
0000028823-23-000117-xbrl.zip	Edgar Link	pending
dbd-20230331.htm	Edgar Link	pending
dbd-20230331.xsd	Edgar Link	pending
dbd3312023ex-104.htm	Edgar Link	pending
dbd3312023ex-105.htm	Edgar Link	pending
dbd-20230331_cal.xml	Edgar Link	unprocessable
dbd-20230331_def.xml	Edgar Link	unprocessable
dbd-20230331_pre.xml	Edgar Link	unprocessable
dbd-20230331_lab.xml	Edgar Link	unprocessable
dbd-20230331_htm.xml	Edgar Link	completed
dbd3312023ex-106.htm	Edgar Link	pending
dbd3312023ex-211.htm	Edgar Link	pending
dbd3312023ex221.htm	Edgar Link	pending
dbd3312023ex311.htm	Edgar Link	pending
dbd3312023ex312.htm	Edgar Link	pending
dbd3312023ex321.htm	Edgar Link	pending
dbd3312023ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DBD
DIEBOLD NIXDORF, Inc Stock $dbd

2023 Q2 Form 10-Q Financial Statement

#000002882323000117 Filed on May 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DBD DIEBOLD NIXDORF, Inc Stock $dbd

2023 Q2 Form 10-Q Financial Statement

#000002882323000117 Filed on May 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DBD
DIEBOLD NIXDORF, Inc Stock $dbd